Literature DB >> 9593666

Nuclear opioid receptors activate opioid peptide gene transcription in isolated myocardial nuclei.

C Ventura1, M Maioli, G Pintus, A M Posadino, B Tadolini.   

Abstract

Opioid-binding sites were identified in highly purified nuclei isolated from hamster ventricular myocardial cells. A significant increase in the maximal binding capacity for a kappa opioid receptor ligand was observed in myocardial nuclei from BIO 14.6 cardiomyopathic hamsters, as compared with nuclei obtained from normal myocytes of the F1B strain. The exposure of isolated nuclei to dynorphin B, a natural agonist of kappa opioid receptors, markedly increased opioid peptide gene transcription. The transcriptional effect was mediated by nuclear protein kinase C activation and occurred at a higher rate in nuclei from cardiomyopathic myocytes than in nuclei isolated from normal cells. Thus, a nuclear endorphinergic system may play an intracrine role in the regulation of gene transcription under both normal and pathological conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9593666     DOI: 10.1074/jbc.273.22.13383

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

Review 1.  The physiological basis of intracrine stem cell regulation.

Authors:  Richard N Re; Julia L Cook
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-13       Impact factor: 4.733

Review 2.  Dynorphins in Development and Disease: Implications for Cardiovascular Disease.

Authors:  Cody Cissom; Jason J Paris; Zia Shariat-Madar
Journal:  Curr Mol Med       Date:  2020       Impact factor: 2.222

Review 3.  G protein-coupled receptor signalling in the cardiac nuclear membrane: evidence and possible roles in physiological and pathophysiological function.

Authors:  Artavazd Tadevosyan; George Vaniotis; Bruce G Allen; Terence E Hébert; Stanley Nattel
Journal:  J Physiol       Date:  2011-12-19       Impact factor: 5.182

Review 4.  Opioid receptors and cardioprotection - 'opioidergic conditioning' of the heart.

Authors:  John P Headrick; Louise E See Hoe; Eugene F Du Toit; Jason N Peart
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

Review 5.  Molecular mechanisms of actions of interleukin-6 on the brain, with special reference to serotonin and the hypothalamo-pituitary-adrenocortical axis.

Authors:  N Barkhudaryan; A J Dunn
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

6.  Requirement of receptor internalization for opioid stimulation of mitogen-activated protein kinase: biochemical and immunofluorescence confocal microscopic evidence.

Authors:  E G Ignatova; M M Belcheva; L M Bohn; M C Neuman; C J Coscia
Journal:  J Neurosci       Date:  1999-01-01       Impact factor: 6.167

7.  Intracrine endothelin signaling evokes IP3-dependent increases in nucleoplasmic Ca²⁺ in adult cardiac myocytes.

Authors:  Clémence Merlen; Nada Farhat; Xiaoyan Luo; David Chatenet; Artavazd Tadevosyan; Louis R Villeneuve; Marc-Antoine Gillis; Stanley Nattel; Eric Thorin; Alain Fournier; Bruce G Allen
Journal:  J Mol Cell Cardiol       Date:  2013-06-10       Impact factor: 5.000

Review 8.  Intracrine Endorphinergic Systems in Modulation of Myocardial Differentiation.

Authors:  Silvia Canaider; Federica Facchin; Riccardo Tassinari; Claudia Cavallini; Elena Olivi; Valentina Taglioli; Chiara Zannini; Eva Bianconi; Margherita Maioli; Carlo Ventura
Journal:  Int J Mol Sci       Date:  2019-10-18       Impact factor: 5.923

Review 9.  Endogenous Opioids and Their Role in Stem Cell Biology and Tissue Rescue.

Authors:  Giovannamaria Petrocelli; Luca Pampanella; Provvidenza M Abruzzo; Carlo Ventura; Silvia Canaider; Federica Facchin
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

10.  Role of Endogenous Opioid System in Ischemic-Induced Late Preconditioning.

Authors:  Jan Fraessdorf; Markus W Hollmann; Iris Hanschmann; André Heinen; Nina C Weber; Benedikt Preckel; Ragnar Huhn
Journal:  PLoS One       Date:  2015-07-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.